Drug intelligence / Profile preview

Orthix Plus

Development stage: Unknown
Administration: Intraarticular

Overview

Orthix Plus is a product used in the management of symptoms associated with osteoarthritis of the knee, notably for pain relief and improvement in joint function[4]. Details regarding its specific composition, mechanism of action, and manufacturer are not fully provided in the available sources. The name and context suggest it may be a specialized formulation for intra-articular administration in osteoarthritis, possibly involving viscosupplementation or adjunct therapies, but exact active ingredients are not explicitly confirmed in the sources[4].

Brand names: Orthix Plus
Other names: Orthix Plus

Beyond the preview

Go deeper on Orthix Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orthix Plus.

Explore the full profile